NATERA, INC. (NTRA) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $14.00K; Additional Paid in Capital, Common StockUSD $4.75B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-108.00K; Retained Earnings (Accumulated Deficit)USD $-2.93B.
- 2026-03-31: Common Stock, Value, IssuedUSD $14.00K; Additional Paid in Capital, Common StockUSD $4.64B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-202.00K; Retained Earnings (Accumulated Deficit)USD $-2.86B.
- 2025-12-31: Common Stock, Value, IssuedUSD $14.00K; Additional Paid in Capital, Common StockUSD $4.49B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-258.00K; Retained Earnings (Accumulated Deficit)USD $-2.78B.
- 2025-09-30: Common Stock, Value, IssuedUSD $14.00K; Additional Paid in Capital, Common StockUSD $4.08B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-187.00K; Retained Earnings (Accumulated Deficit)USD $-2.82B.
NATERA, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $14.00K | $4.75B | $-108.00K | $-2.93B | $1.82B | 6 month · $47.03M | 3 month · $102.09M 6 month · $196.16M | (m) | (m) | (m) |
| 2026-03-31 | $14.00K | $4.64B | $-202.00K | $-2.86B | $1.77B | 3 month · $47.03M | 3 month · $94.07M | (m) | (m) | (m) |
| 2025-12-31 | $14.00K | $4.49B | $-258.00K | $-2.78B | $1.71B | 12 month · $32.88M | 12 month · $357.30M | (m) | (m) | (m) |
| 2025-09-30 | $14.00K | $4.08B | $-187.00K | $-2.82B | $1.25B | 9 month · $32.88M | 3 month · $91.52M 9 month · $264.10M | (m) | (m) | (m) |
| 2025-06-30 | $14.00K | $3.98B | $-287.00K | $-2.74B | $1.25B | 3 month · $812.00K 6 month · $32.88M | 3 month · $94.15M 6 month · $172.58M | (m) | (m) | (m) |
| 2025-03-31 | $14.00K | $3.87B | $-197.00K | $-2.63B | $1.24B | 3 month · $32.06M | 3 month · $78.44M | (m) | (m) | (m) |
| 2024-12-31 | $12.00K | $3.76B | $-344.00K | $-2.57B | $1.20B | 12 month · $24.07M | 12 month · $276.69M | (m) | (m) | (m) |
| 2024-09-30 | $12.00K | $3.39B | $-765.00K | $-2.51B | $878.52M | 9 month · $24.07M | 3 month · $71.28M 9 month · $204.23M | (m) | (m) | (m) |
| 2024-06-30 | $12.00K | $3.32B | $-1.36M | $-2.48B | $836.52M | 6 month · $24.07M | 3 month · $68.00M 6 month · $132.95M | (m) | (m) | (m) |
| 2024-03-31 | $12.00K | $3.24B | $-2.19M | $-2.45B | $794.11M | 3 month · $24.07M | 3 month · $64.95M | (m) | (m) | (m) |
| 2023-12-31 | $11.00K | $3.15B | $-3.08M | $-2.38B | $765.33M | 12 month · $19.77M | 12 month · $192.44M | (m) | (m) | (m) |
| 2023-09-30 | $11.00K | $3.09B | $-5.40M | $-2.30B | $784.66M | 9 month · $19.77M | 3 month · $57.73M 9 month · $142.90M | (m) | (m) | (m) |
| 2023-06-30 | $11.00K | $2.80B | $-9.20M | $-2.19B | $596.15M | 6 month · $19.77M | 3 month · $44.47M 6 month · $85.17M | (m) | (m) | (m) |
| 2023-03-31 | $11.00K | $2.74B | $-11.80M | $-2.08B | $650.57M | 3 month · $19.77M | 3 month · $40.70M | (m) | (m) | (m) |
| 2022-12-31 | $11.00K | $2.66B | $-16.36M | $-1.94B | $705.74M | (m) | 12 month · $152.38M | (m) | (m) | (m) |
| 2022-09-30 | $10.00K | $2.18B | $-19.61M | $-1.80B | $361.62M | (m) | 3 month · $40.34M 9 month · $116.40M | (m) | (m) | (m) |
| 2022-06-30 | $10.00K | $2.14B | $-16.40M | $-1.68B | $444.58M | (m) | 3 month · $40.97M 6 month · $76.06M | (m) | (m) | (m) |
| 2022-03-31 | $10.00K | $2.09B | $-13.90M | $-1.53B | $542.34M | (m) | 3 month · $35.09M | (m) | (m) | (m) |
| 2021-12-31 | $10.00K | $2.05B | $-2.29M | $-1.39B | $653.30M | (m) | 12 month · $115.22M | (m) | (m) | (m) |
| 2021-09-30 | $10.00K | $2.01B | $1.49M | $-1.25B | $759.02M | (m) | 3 month · $26.46M 9 month · $84.80M | (m) | (m) | (m) |
| 2021-06-30 | $9.00K | $1.40B | $2.44M | $-1.10B | $299.11M | (m) | 3 month · $35.10M 6 month · $58.34M | (m) | (m) | (m) |
| 2021-03-31 | $9.00K | $1.36B | $3.20M | $-986.97M | $372.44M | (m) | 3 month · $23.23M | (m) | (m) | (m) |
| 2020-12-31 | $9.00K | $1.41B | $4.26M | $-929.32M | $486.24M | (m) | 12 month · $50.17M | 12 month · $82.87M | (m) | (m) |
| 2020-09-30 | $9.00K | $1.38B | $5.17M | $-852.91M | $536.00M | (m) | 3 month · $15.03M 9 month · $34.41M | 9 month · $82.87M | (m) | (m) |
| 2020-06-30 | $8.00K | $1.09B | $5.77M | $-794.58M | $304.27M | (m) | 3 month · $11.96M 6 month · $19.37M | 3 month · $82.87M 6 month · $82.87M | (m) | (m) |
| 2020-03-31 | $8.00K | $988.20M | $5.67M | $-734.95M | $258.93M | (m) | 3 month · $7.42M | (m) | (m) | (m) |
| 2019-12-31 | $8.00K | $976.96M | $919.00K | $-699.17M | $278.71M | (m) | 12 month · $28.62M | (m) | (m) | (m) |
| 2019-09-30 | $7.00K | $747.82M | $858.00K | $-663.99M | $84.69M | (m) | 3 month · $10.25M 9 month · $20.10M | (m) | (m) | (m) |
| 2019-06-30 | $7.00K | $733.14M | $795.00K | $-640.85M | $93.09M | (m) | 3 month · $5.80M 6 month · $9.86M | (m) | (m) | (m) |
| 2019-03-31 | $7.00K | $613.68M | $-266.00K | $-699.20M | $4.99M | (m) | 3 month · $4.05M | (m) | (m) | (m) |
| 2018-12-31 | $7.00K | $607.24M | $-552.00K | $-574.53M | $32.16M | (m) | 12 month · $14.20M | (m) | (m) | (m) |
| 2018-09-30 | $7.00K | $600.15M | $-894.00K | $-542.69M | $56.57M | (m) | 3 month · $3.62M 9 month · $10.14M | (m) | (m) | (m) |
| 2018-06-30 | $6.00K | $491.89M | $-858.00K | $-513.07M | $-22.04M | (m) | 3 month · $3.37M 6 month · $6.52M | (m) | (m) | 6 month · $-32.00K |
| 2018-03-31 | $6.00K | $476.27M | $-904.00K | $-479.25M | $-3.88M | (m) | 3 month · $3.15M | (m) | (m) | 3 month · $-32.00K |
| 2017-12-31 | $6.00K | $472.55M | $-766.00K | $-446.38M | $25.42M | (m) | 12 month · $11.40M | (m) | (m) | (m) |
| 2017-09-30 | $6.00K | $467.23M | $-396.00K | $-436.66M | $30.18M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $6.00K | $460.91M | $-463.00K | $-409.54M | $50.91M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $6.00K | $456.00M | $-525.00K | $-381.81M | $73.67M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $5.00K | $453.04M | $-725.00K | $-345.85M | $143.58M | (m) | 12 month · $10.60M | (m) | (m) | (m) |
| 2016-09-30 | $6.00K | $447.92M | $334.00K | $-307.94M | $140.31M | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $6.00K | $444.79M | $943.00K | $-281.92M | $163.81M | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $6.00K | $439.96M | $396.00K | $-258.77M | $181.59M | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $5.00K | $436.26M | $-1.42M | $-250.08M | $226.43M | (m) | 12 month · $7.33M | (m) | 12 month · $4.04M | 12 month · $0.00 |
| 2015-09-30 | $5.00K | $433.14M | $36.00K | $-227.12M | $206.06M | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $1.00K | $11.72M | (m) | $-209.49M | $-197.77M | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $1.00K | $8.66M | (m) | $-179.81M | $-171.34M | (m) | 12 month · $5.16M | (m) | (m) | 12 month · $0.00 |
| 2013-12-31 | (m) | (m) | (m) | (m) | $-171.51M | (m) | 12 month · $1.66M | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | $-136.31M | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |